Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

EC Clears DSM Sale Of Benzoates Unit

by Michael McCoy
December 13, 2010 | A version of this story appeared in Volume 88, Issue 50

The European Commission has approved DSM’s sale of its DSM Special Products business in Rotterdam, the Netherlands, to Sun Capital Partners. The sale had come before the EC because Sun’s Emerald Performance Materials affiliate in the U.S. and DSM are two of only a few world producers of benzoic acid, benzyl alcohol, and benzaldehyde. The commission blocked DSM’s earlier attempt to sell the business to Arsenal Capital Partners, a firm that controlled a European benzoic acid plant. This time, though, the EC concluded that “the transaction would not significantly impede effective competition in the European Economic Area.”

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.